(Q45877856)

17 December 2017

title

Cancer-specific activation of the survivin promoter and its potential use in gene therapy (English)

1 reference

17 December 2017

0 references

1

1 reference

17 December 2017

Mien-Chie Hung

10

object named as

Mien-Chie Hung

1 reference

17 December 2017

Jaw-Ching Liu

2

object named as

Jaw-Ching Liu

1 reference

17 December 2017

Hsu-Ping Kuo

5

object named as

Hsu-Ping Kuo

1 reference

17 December 2017

author name string

Lei Shen

3

1 reference

17 December 2017

Kung-Ming Rau

4

1 reference

17 December 2017

Yan M Li

6

1 reference

17 December 2017

Daren Shi

7

1 reference

17 December 2017

Yung-Chie Lee

8

1 reference

17 December 2017

King-Jen Chang

9

1 reference

17 December 2017

publication date

1 November 2004

1 reference

17 December 2017

published in

Cancer Gene Therapy

1 reference

17 December 2017

volume

11

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

740-747

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700752

exact match

0 references

cites work

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Improved DNA: liposome complexes for increased systemic delivery and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Mechanism-based target identification and drug discovery in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

The molecular basis and potential role of survivin in cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Survivin gene expression in early-stage non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Expression and prognostic significance of survivin in de novo acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Activation of cancer-specific gene expression by the survivin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Analysis of human transcriptomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Cancer gene therapy using a survivin mutant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Validating survivin as a cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Selective activation of ceruloplasmin promoter in ovarian tumors: potential use for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Induction of human gamma globin gene expression by histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

inferred from DOI database lookup

7 January 2021

based on heuristic

Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700752

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700752

1 reference

17 December 2017

Dimensions Publication ID

1033981091

0 references

1 reference

17 December 2017